PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026Stroke0 citations

Abstract WP219: Angiographic Predictors of Retreatment After Onyx Middle Meningeal Artery Embolization for Aubacute/Chronic Subdural Hematoma: an EMBOLISE subset analysis

View Full Paper
AHAmeer HassanSMSamantha MillerMMMaxim Mokin

Key Points

  • This analysis aims to identify clinical and angiographic predictors of retreatment following MMA embolization for subdural hematoma.
  • Post-hoc analysis of EMBOLISE Surgery Cohort with Onyx treatment.
  • Comparison of retreatment (≤90 days) vs no retreatment groups.
  • Assessment of demographics, antithrombotic use, and angiographic features.
  • Statistical analysis using Fisher’s exact and unpaired t-tests.
  • Retreatment group trended higher in antiplatelet/anticoagulant use at symptom onset (75% vs 36.5%, p=0.056).
  • Persistent late contrast filling of proximal MMA branches was found in 100% of retreated vs 35.8% of non-retreated (p=0.0026).
  • 'Proximal occlusion only' pattern was absent in retreatment group vs present in 53.6% of non-retreated (p=0.011).
  • Demographics and procedural metrics were similar between the two groups.

Abstract

Background: Some patients require retreatment after MMA embolization for subacute/chronic subdural hematoma (SDH). We evaluated clinical, imaging, and angiographic features associated with retreatment. Methods: Post-hoc analysis of EMBOLISE Surgery Cohort subjects treated with Onyx. Groups were defined by retreatment ≤90 days (Retreated, N=8) vs no retreatment (N=189). Variables included demographics, antithrombotic use, SDH morphology, core-lab–read hematoma metrics, embolization extent, Onyx distribution, and late contrast filling after embolization. Fisher’s exact and unpaired t-tests were used. Results: Age (73.9±9.1 vs 72.9±11.1 years, p=0.81), SDH thickness (19.8±7.7 vs 21.3±5.9 mm, p=0.48), midline shift (5.6±2.0 vs 7.1±3.7 mm, p=0.23), Onyx volume (0.88±0.47 vs 0.85±0.66 mL, p=0.93), fluoroscopy time (31.0±15.8 vs 28.3±13.5 min, p=0.58), and procedure time (69.0±29.6 vs 63.7±31.0 min, p=0.64) did not differ. Antiplatelet/anticoagulant use at symptom onset trended higher in the Retreated group (75.0% vs 36.5%, p=0.056). Core-lab angiography showed an association with retreatment: late contrast filling of proximal MMA branches after embolization occurred in 100% of Retreated vs 35.8% of non-Retreated (p=0.0026), whereas a “proximal occlusion only” late-filling pattern was absent in Retreated vs present in 53.6% of non-Retreated (p=0.011). SDH location and morphology and subdural membrane filling change were not different, though “no change” in membrane filling trended higher in Retreated (16.7% vs 0.56%, p=0.064). Conclusions: Retreatment rates after Onyx MMA embolization in the EMBOLISE study were quite low to make meaningful conclusions. Demographics, hematoma thickness, midline shift, and procedural metrics were similar between the retreated vs non-retreated groups. There was a trend toward retreatment being associated with persistent late filling of proximal MMA branches. However, distribution of Onyx was proximal in 50% and distal in 50% of the retreated subjects. Thus, the role of distal embolization is unclear. Further pooling of large studies is needed to understand factors influencing retreatments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hassan et al. (2026) studied this question.

synapsesocial.com/papers/6980fd60c1c9540dea80f159https://doi.org/10.1161/str.57.suppl_1.wp219
Ask AI
Helpful
Bookmark
Share
View Full Paper